Comments
Pharma major Dr Reddy’s Laboratories' US subsidiary, Promius Pharma, has launched Sernivo (betamethasone dipropionate) Spray in the US.
Sernivo Spray, a prescription topical steroid approved by the Food and Drug Administration (FDA) in February of 2016, is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.
This was announced by Raghav Chari, Executive Vice-President, Proprietary Products Group at Dr Reddy’s Laboratories in a release issued here on Wednesday.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.